• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to footer

ZEG Berlin GmbH

Zentrum für Epidemiologie und Gesundheitsforschung

  • Home
  • Expertise
    • Real-World Evidence
    • Non-interventional study design
    • Post-authorization safety studies
    • Post-authorization efficacy studies
    • Cohort studies
    • Case-control studies
    • Medical Devices
    • Data collection instruments
  • Services
    • RWE Services
    • Crisis Management
    • Consulting
    • Data Management and Biostatistics
    • Medical Writing
    • Study Management
    • Quality Assurance
    • Pharmacovigilance
  • Library & News
    • News/Conferences
    • Publications
  • PROs
    • Menopause Rating Scale
      • Menopause Rating Scale (MRS) – Languages
    • Aging Male Symptoms Scale
      • AMS – properties as an outcome measure
      • AMS – properties as a screening tool
    • Quality of Sexual Function Scale
      • Quality of Sexual Function Scale
    • Short Term Hormone Effect Scale
      • Short Term Hormone Effect Scale
    • Research team
  • About Us
    • Who We Are
      • Management Board
      • Executive Team
      • Project Management Team
    • History
    • Careers
    • Data Protection Information
  • Contact

Publications

Heinemann Klaas, Assmann Anita, Long term active surveillance study for oral contraceptives (LASS): final results on cardiovascular safety. Pharmacoepidemiology and Drug Safety. 2012; Aug; 21(S3) 360. DOI 10.1002.
Barnett Clare, Heinemann Klaas, Dinger Jürgen, Intrauterine devices and risk of uterine perforations: interim results from the EURAS-IUD study. Pharmacoepidemiology and Drug Safety. 2012; Aug; 21(S2) 45. DOI 10.1002.
Dinger Jürgen, Bardenheuer Kristina, M Kieble, Informationsquellen von seltenen schwerwiegenden Erkrankungen: Arzt oder Patient? . Abstractband der 7. Jahrestagung der Deutschen Gesellschaft für Epidemiologie,. 2012; Sept: 133(P1).
Bardenheuer Kristina, Kern S, Leddin Janko, Unterschiedliches Verschreibungsverhalten der "Pille" bei Jugendlichen und Erwachsenen. . Abstractband der 7. Jahrestagung der Deutschen Gesellschaft für Epidemiologie,. 2012; Sept: 194(P118).
Rabe T, Luxembourg B, Dinger Jürgen, Kontrazeption & Thrombophilie - Eine Stellungnahme der Deutschen Gesellschaft für Gynäkologische Endokrinologie und Fortpflanzungsmedizin (DGGEF) e.V. und des Berufsverbands für Frauenärzte (BVF) e.V. . Journal of Reproductive Medicine and Endocrinology. 2012; Sept:(1):20-63.
Rabe T, Luxembourg B, Ludwig M, Dinger Jürgen, Bauersachs R, Rott H, Mueck A O, Albring C, Thrombophilie und/oder Z. n. Thromboembolie: Auswahl der richtigen Kontrazeption - Teil 3: Vorgehen bei Risikogruppen. . Gyne Fachzeitschrift für den Arzt der Frau. 2012; Apr;33 Jahrgang.
Rabe T, Luxembourg B, Ludwig M, Dinger Jürgen, Bauersachs R, Rott H, Mueck A O, Albring C, Thrombophilie und/oder Z. n. Thromboembolie: Auswahl der richtigen Kontrazeption - Teil 2: Vorgehen bei Risikogruppen. . Gyne Fachzeitschrift für den Arzt der Frau. 2012; Jan;32 Jahrgang.
Heinemann Lothar A , Do Minh Thai, Heinemann Klaas, Lindemann M , Filonenko A, Intercountry assessment of the impact of severe premenstrual disorders on work and daily activities. Health Care Women International. 2012; Feb;33(2):109-24.
Dinger Jürgen, M Kieble, Rare serious adverse events: comparison of patient- and physician-reported outcomes. Pharmacoepidemiology and Drug Safety. 2012; Aug; 21(S3) 732. DOI 10.1002.
Dinger Jürgen, Assmann Anita, Oral contraceptives and the risk of VTE: reanalysis of the EURAS/LASS study. Pharmacoepidemiology and Drug Safety. 2011; Aug: 20(S1) 74.
Rabe T, Luxembourg B, Ludwig M, Dinger Jürgen, Bauersachs R, Rott H, Mueck A O, Albring C, Thrombophilie und/oder Z. n. Thromboembolie: Auswahl der richtigen Kontrazeption - Teil 1: Vorgehen bei Risikogruppen. . Gyne Fachzeitschrift für den Arzt der Frau,. 2011; Dec;32 Jahrgang.
Dinger Jürgen, Bardenheuer Kristina, Assmann Anita, Safety and effectiveness of oral contraceptives in obese women. Pharmacoepidemiology and Drug Safety. 2011; Aug: 20(S1) 15.
  • « Go to Previous Page
  • Page 1
  • Interim pages omitted …
  • Page 7
  • Page 8
  • Page 9
  • Page 10
  • Page 11
  • Interim pages omitted …
  • Page 22
  • Go to Next Page »

sidebar

Search our Publications

sidebar-alt

Footer

ZEG Berlin

Berlin Center for Epidemiology and Health Research

Invalidenstraße 115
10115 Berlin
Germany

Contact Us

Expertise

  • Real-World Evidence
  • Non-interventional study design
  • Post-authorization safety studies
  • Post-authorization efficacy studies
  • Cohort studies
  • Case-control studies
  • Medical Devices
  • Patient Reported Outcomes (PROs)
  • Data collection instruments

Services

  • Crisis Management
  • Consulting
  • Data Management and Biostatistics
  • Medical Writing
  • Study Management
  • Quality Assurance
  • Pharmacovigilance

ENCePP

We are a partner centre of the ENCePP scientific network which is coordinated by the European Medicines Agency. We are dedicated to excellence in research by adhering to the ENCePP Guide on Methodological Standards and promoting scientific independence and transparency. We register studies in the ENCePP E-Register of Studies, a publicly accessible resource for the registration of pharmacoepidemiological and pharmacovigilance studies.

General Data Protection Regulation

With a view to the introduction of the GDPR/EUDSGVO we are glad to present our newupdated privacy policy . The updated description are stored under “about us” and then “privacy policy/GDPR”. Further translation for study participants will follow contemporary.

© 2011–2025 ZEG Berlin

Impressum

Website by Laura Yeffeth.